News

Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug
CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...
BioSpace3d
Lilly’s Zepbound Secures “Superior Benefit-Risk Ratio” Over Novo’s Wegovy
In addition to eliciting greater weight loss than Novo Nordisk’s Wegovy, Eli Lilly’s Zepbound does not come at the expense of ...
Best Life on MSN2d
Weight-Loss Drugs Could Slash Cancer Risk by 41%—Here’s Who Benefits
Participants in a new study who used GLP-1 drugs had a much lower cancer risk than those who had bariatric surgery.
Pharmaceutical Technology on MSN2d
GLP-1RAs show anti-cancer benefits beyond weight loss
GlobalData analysis predicts the global GLP-1RA market will reach $168bn by 2033, with Novo Nordisk and Eli Lilly to dominate ...
The Hill6d
Do Medicare, Medicaid cover weight loss drugs? It depends
Wellcare, which offers Medicare Advantage and Medicare ... Medicare covers Zepbound for that purpose. It does not cover it solely for weight loss. Patients paying the list price for the ...
Wellness companies embrace weight-loss drugs in bid to avoid fate of WeightWatchers
Health retailer The Vitamin Shoppe has seen a spike in demand for supplements that could help with loss of appetite, ...
Beyond Valuation Ratios: 3 Undervalued Stocks To Buy In May 2025
Looking for undervalued stocks? Check out three top undervalued stocks to buy now in May, 2025 to boost your portfolio.
AOL5d
Wellness companies eager to avoid WeightWatchers' fate embrace weight-loss drugs
Other health companies see room for products and services that take advantage of the popularity of new weight-loss ...